These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4539796)

  • 1. [L-dopa treatment of idiopathic orthostatic hypotension (postural hypotension)].
    Maier C
    Schweiz Med Wochenschr; 1972 Oct; 102(40):1412-4. PubMed ID: 4539796
    [No Abstract]   [Full Text] [Related]  

  • 2. Etilefrine in the treatment of levodopa-induced orthostatic hypotension.
    Miller E; Wiener L; Bloomfield D
    Arch Neurol; 1973 Aug; 29(2):99-103. PubMed ID: 4577820
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of L-threo-Dops on orthostatic hypotension in Parkinson's disease].
    Yanagisawa N; Ikeda S; Hashimoto T; Hanyu N; Nakagawa S; Fujimori N; Ushiyama M
    No To Shinkei; 1998 Feb; 50(2):157-63. PubMed ID: 9513205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Letter: Arterial pressure and cerebral blood flow in parkinsonian patients treated with L Dopa. Their postural regulation].
    Boismare F; Samson M; Brouta M
    Nouv Presse Med; 1973 Oct; 2(38):2552. PubMed ID: 4763463
    [No Abstract]   [Full Text] [Related]  

  • 5. [L-dopa and Parkinson's disease].
    Barbeau A
    Union Med Can; 1970 Dec; 99(12):2195-7. PubMed ID: 5488646
    [No Abstract]   [Full Text] [Related]  

  • 6. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Kaufmann H; Saadia D; Voustianiouk A; Goldstein DS; Holmes C; Yahr MD; Nardin R; Freeman R
    Circulation; 2003 Aug; 108(6):724-8. PubMed ID: 12885750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of idiopathic postural hypotension.
    Lewis RK; Hazelrig CG; Fricke FJ; Russell RO
    Arch Intern Med; 1972 Jun; 129(6):943-9. PubMed ID: 5033289
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rheographic study of postural regulation of cerebral blood flow in parkinsonian patients treated or untreated by L DOPA].
    Boismare F; Samson M; Brouta M
    Therapie; 1973; 28(6):1153-66. PubMed ID: 4794673
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of dihydroergotamine in the prevention and treatment of orthostatic hypotension syndromes in patients with parkinsonism treated with L-dopa].
    Jubert Gruart J; Balcells Riba M
    Arch Neurobiol (Madr); 1974; 37(4):401-12. PubMed ID: 4433212
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiopathic orthostatic hypotension treated with levodopa and MAO inhibitor: a preliminary report.
    Sharpe J; Marquez-Julio A; Ashby P
    Can Med Assoc J; 1972 Aug; 107(4):296-300. PubMed ID: 5056115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Parkinson's syndrome with L-dopa].
    Kaeser HE; Ferel D; Wurmser P
    Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276
    [No Abstract]   [Full Text] [Related]  

  • 12. Postural hypotension and its management.
    Hawkins S; Prout BJ
    Practitioner; 1982 Mar; 226(1365):420-2, 424, 426. PubMed ID: 7045842
    [No Abstract]   [Full Text] [Related]  

  • 13. Levodopa therapy for Parkinsonism in the Shy-Drager syndrome.
    Aminoff MJ; Wilcox CS; Woakes MM; Kremer M
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):350-3. PubMed ID: 4714096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical picture of postural hypotension].
    Gerhard W; von Smekal P
    Z Kreislaufforsch; 1968 Feb; 57(2):108-19. PubMed ID: 4299606
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
    Guillard A
    Brux Med; 1972 Oct; 52(10):673-80. PubMed ID: 4656191
    [No Abstract]   [Full Text] [Related]  

  • 16. Early and late effects of levodopa on the cardiovascular system in Parkinson's disease. A paired study.
    Ballantyne JP
    J Neurol Sci; 1973 May; 19(1):97-103. PubMed ID: 4715025
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dihydroergotamine in orthostatic dysregulation].
    Heck J
    Med Klin; 1971 Apr; 66(16):601-4. PubMed ID: 5552926
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of drug-induced orthostatic circulatory disorders].
    Reckel K
    Ther Ggw; 1970 May; 109(5):694 passim. PubMed ID: 4987184
    [No Abstract]   [Full Text] [Related]  

  • 19. Dihydroergotamine (Dihydergot) in the treatment of orthostatic circulatory disorders: a double-blind comparison with placebo.
    Krüger K; Neff K
    J Med; 1973; 4(2):106-17. PubMed ID: 4584070
    [No Abstract]   [Full Text] [Related]  

  • 20. L-dopa therapy in Parkinson's disease.
    Lipman IJ
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.